Analysis of DNA mismatch repair (MMR) and clinical outcome in stage III colon cancers from patients (pts) treated with adjuvant FOLFOX +/- cetuximab in the PETACC8 and NCCTG N0147 adjuvant trials
2015 Zaanan, Aziz; Shi, Qian; Taieb, Julien; Alberts, Steven R.; Smyrk, Thomas C.; Julie, Catherine; Zawadi, Ayman; Tabernero, Josep; Mini, Enrico; Goldberg, Richard M.; Folprecht, Gunnar; Van Laethem, Jean L.; Le Malicot, Karine; Sargent, Daniel J.; Laurent-Puig, Pierre; Sinicrope, Frank A.
Prognostic value of BRAF V600E and KRAS exon 2 mutations in microsatellite stable (MSS), stage III colon cancers (CC) from patients (pts) treated with adjuvant FOLFOX+/- cetuximab: A pooled analysis of 3934 pts from the PETACC8 and N0147 trials
2015 Taieb, Julien; Le Malicot, Karine; Penault-Llorca, Frederique Madeleine; Bouche, Olivier; Shi, Qian; Thibodeau, Stephen N.; Tabernero, Josep; Mini, Enrico; Goldberg, Richard M.; Folprecht, Gunnar; Van Laethem, Jean-Luc; Sargent, Daniel J.; Alberts, Steven R.; Laurent-Puig, Pierre; Sinicrope, Frank A.
Validation of the prognostic impact of lymphocyte infiltration (LI) in patients (pts) with stage III colon cancer (CC) treated with adjuvant FOLFOX+/- cetuximab: A PETACC8 translational study
2016 Emile, Jean-François; Le Malicot, Karine; Tabernero, Josep; Mini, Enrico; Folprecht, Gunnar; Van Laethem, Jean-Luc; Julie, Catherine; Allard, Marc Antoine; Bennouna, Jaafar; Lepage, Come; Laurent-Puig, Pierre; Taïeb, Julien
PROGNOSTIC VALUE OF KRAS MUTATIONS IN STAGE III COLON CANCER: POST-HOC ANALYSES OF THE PETACC8 PHASE III TRIAL
2014 Taieb, J.; Emile, J. F.; Le Malicot, K.; Zaanan, A.; Tabernero, J.; Mini, E.; Folprecht, G.; Van Laethem, J. L.; Thaler, J.; Bridgewater, J.; Petersen, L.; Van Cutsem, E.; Lepage, C.; Salazar, R.; Laurent-Puig, P.; Blons, H.
PPROGNOSTIC VALUE OF KRAS MUTATIONS IN STAGE III COLON CANCER: POST-HOC ANALYSES OF THE PETACC8 PHASE III TRIAL
2014 Blons, H.; Emile, J.; Le Malicot, K.; Zaanan, A.; Tabernero, J.; Mini, E.; Folprecht, G.; van Laethem, J.; Thaler, J.; Bridgewater, J.A.; Petersen, L.; Van Cutsem, E.; Lepage, C.; Salazar, R.; Laurent-Puig, P.; Taieb, J.
Analysis of DNA mismatch repair and clinical outcome in stage III colon cancers from patients treated with adjuvant FOLFOX +/- cetuximab in the PETACC8 and NCCTG N0147 adjuvant trials
2015 Zaanan, A.; Shi, Q.; Taieb, J.; Alberts, S.; Smyrk, T.; Julie, C.; Zawadi, A.; Tabernero, J.; Mini, E.; Goldberg, R.; Folprecht, G.; Van Laethem, J.L.; Le Malicot, K.; Sargent, D.; Laurent Puig, P.; Sinicrope, F.
Prognostic value of BRAFV600E and KRAS exon 2 mutations in microsatellite stable stage III colon cancers from patients treated with FOLFOX + /- cetuximab: A pooled analysis from PETACC8 and N0147 trials
2015 Taieb, J.; Le Malicot, K.; Penault-Llorca, F.; Bouche, O.; Shi, Q.; Thibodeau, S.; Tabernero, J.; Mini, E.; Zaanan, Z.; Goldberg, R.; Folprecht, G.; Van Laethem, J.L.; Sargent, D.; Alberts, S.; Laurent Puig, P.; Sinicrope, F.
Association of prognostic value of primary tumor location in stage III colon cancer with RAS and BRAF mutational status
2017 Taieb, Julien; Kourie, Hampig Raphael; Emile, Jean-François; Le Malicot, Karine; Balogoun, Ralyath; Tabernero, Josep; Mini, Enrico; Folprecht, Gunnar; Van Laethem, Jean-Luc; Mulot, Claire; Bouche, Olivier; Aparicio, Thomas; Michel, Pierre; Thaler, Josef; Bridgewater, John A.; Van Cutsem, Eric; Perkins, Géraldine; Salazar, Ramon; Lepage, Come; Laurent-Puig, Pierre
Preliminary efficacy and safety data of nivolumab in never smoker patients with advanced squamous NSCLC: Experience from Italian sites participating in the Expanded Access Programme (EAP)
2016 Vitali, M.; Crinò, L.; Logroscino, A.F.; Ardizzoni, A.; Caponnetto, S.; Landi, L.; Bordi, P.; Luana, C.; Barbieri, F.; Santo, A.; Santarpia, M.; Carteni, G.; Mini, E.; Vasile, E.; Morgillo, F.; De Galitiis, F.; Conca, R.; Macerelli, M.; Tedde, N.; Vitiello, F.
Prognostic value of primary tumor location in stage III colon cancer is associated with RAS and BRAF mutational status
2017 Taieb, Julien; Kourie Hampig, Raphael; Emile Jean, François; Le Malicot, Karine; Balogoun, Ralyath; Tabernero, Josep; Mini, Enrico; Folprecht, Gunnar; Van Laethem Jean, Luc; Mulot, Claire; Bouché, Olivier; Aparicio, Thomas; Michel, Pierre; Thaler, Josef; Bridgewater, John; Van Cutsem, Eric; Perkins, Géraldine; Lepage, Come; Salazar, Ramon; Laurent Puig, Pierre
Italian nivolumab expanded access programme in non-squamous non-small cell lung cancer patients: Real-world results in never smokers and EGFR positive patients
2017 Garassino, M.C.; Cortesi, E.; Grossi, F.; Chiari, R.; Soto Parra, H.J.; Cascinu, S.; Cognetti, F.; Turci, D.; Blasi, L.; Bengala, C.; Mini, E.; Baldini, E.E.; Gamucci, T.; Ceresoli, G.L.; Antonelli, P.; Vasile, E.; Pagano, M.; Macerelli, M.; Lagroscino, A.; De Marinis, F.
Inflammatory indexes strongly predict clinical outcome in patients (pts) with metastatic renal cell cancer (mRCC) treated with nivolumab: results from the Italian expanded access program (EAP)
2017 De Giorgi, U.; Procopio, G.; Guida, A.; Bearz, A.; Buti, S.; Basso, U.; Mitterer, M.; Ortega, C.; Bidoli, P.; Ferrau, F.; Crinò, L.; Frassoldati, A.; Marchetti, P.; Mini, E.; Scoppola, A.; Verusio, C.; Fornarini, G.; Cartenì, G.; Caserta, C.; Sternberg, C.N.
Prognostic value of methylator phenotype in stage III colon cancer treated with oxaliplatin-based adjuvant chemotherapy
2017 Gallois, C.; Taieb, J.; Le Corre, D.; Le Malicot, K.; Tabernero, J.; Mulot, C.; Seitz, J-F.; Aparicio, T.; Folprecht, G.; Lepage, C.; Mini, E.; Van Laethem, J-L.; Emile, J.F.; Laurent-Puig, P.
Retrospective analysis of 77 patients with ovarian cancer undergoing genetic testing for BRCA1 and BRCA2 mutations
2017 Tavella, K; Villanucci, A; Vannini, L; Rossi, V; Fantechi, B; Capone, G; Putignano, A L; Gensini, F; Porfirio, B; Amunni, G; Mazzei, T; Mini, E; Papi, L
Association of postoperative carcinoembryonic antigen (CEA) levels with survival in stage III colon cancer (CC): Post hoc analysis of the MOSAIC and PETACC-8 studies
2018 Auclin, Edouard; Taieb, Julien; Lepage, Come; Aparicio, Thomas; Faroux, Roger; Mini, Enrico; Folprecht, Gunnar; Salazar, Ramon; Banzi, Maria; Louvet, Christophe; Van Laethem, Jean-Luc; Tabernero, Josep; Hickish, Tamas; De Gramont, Aimery; Andre, Thierry; Vernerey, Dewi
Relative contribution of clinical and molecular features to outcome within low and high risk T and N groups in stage III colon cancer (CC)
2019 Sinicrope, Frank A.; Huebner, Lucas J.; Laurent-Puig, Pierre; Smyrk, Thomas C.; Tabernero, Josep; Mini, Enrico; Goldberg, Richard M.; Folprecht, Gunnar; Zaanan, Aziz; Le Malicot, Karine; Shi, Qian; Alberts, Steven R; Taieb, Julien
Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor)
2019 Gasperoni S, Messerini L, Fumagalli E, Manglaviti S, Vincenzi B, Mazzocca Jr. A, Pantaleo MA, Nannini M, Badalamenti G, Incorvaia L, Ottaviano M, Palmieri G, Grignani G, D'Ambrosio L, Meoni G, Paderi A, Fancelli S, Caliman E, Tofani L, Enrico Mini.
Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab
2019 De Giorgi, Ugo; Procopio, Giuseppe; Sabbatini, Roberto; Caserta, Claudia; Mitterer, Manfred; Ortega, Cinzia; Scoppola, Alessandro; Fornarini, Giuseppe; Ferraú, Francesco; Marchetti, Paolo; Verusio, Claudio; Mini, Enrico; Bidoli, Paolo; Buti, Sebastiano; Crino, Lucio; Basso, Umberto; Frassoldati, Antonio; Bearz, Alessandra; Carteni, Giacomo; Sternberg, Cora N.
Is the predictive and prognostic impact of sporadic and familial microsatellite instable stage III colon cancer different? A pooled analysis of the PETACC8 and NCCTG N0147 (Alliance) trials
2019 Zaanan, Aziz; Shi, Qian; Taieb, Julien; Alberts, Steven R; Meyers, Jeffrey P.; Smyrk, Thomas C.; Julié, Catherine; Zawadi, Ayman; Tabernero, Josep; Mini, Enrico; Goldberg, Richard M.; Folprecht, Gunnar; VAN Laethem, Jean Luc; Le Malicot, Karine; Sargent, Daniel J.; Laurent-Puig, Pierre; Sinicrope, Frank A.
Preface
2019 Brugnano, Luigi; Jackiewicz, Zdzisław; Podhaisky, Helmut; Sun, Yajuan; Tischendorf, Caren
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Analysis of DNA mismatch repair (MMR) and clinical outcome in stage III colon cancers from patients (pts) treated with adjuvant FOLFOX +/- cetuximab in the PETACC8 and NCCTG N0147 adjuvant trials | 2015 | Zaanan, Aziz; Shi, Qian; Taieb, Julien; Alberts, Steven R.; Smyrk, Thomas C.; Julie, Catherine; Zawadi, Ayman; Tabernero, Josep; Mini, Enrico; Goldberg, Richard M.; Folprecht, Gunnar; Van Laethem, Jean L.; Le Malicot, Karine; Sargent, Daniel J.; Laurent-Puig, Pierre; Sinicrope, Frank A. | |
| Prognostic value of BRAF V600E and KRAS exon 2 mutations in microsatellite stable (MSS), stage III colon cancers (CC) from patients (pts) treated with adjuvant FOLFOX+/- cetuximab: A pooled analysis of 3934 pts from the PETACC8 and N0147 trials | 2015 | Taieb, Julien; Le Malicot, Karine; Penault-Llorca, Frederique Madeleine; Bouche, Olivier; Shi, Qian; Thibodeau, Stephen N.; Tabernero, Josep; Mini, Enrico; Goldberg, Richard M.; Folprecht, Gunnar; Van Laethem, Jean-Luc; Sargent, Daniel J.; Alberts, Steven R.; Laurent-Puig, Pierre; Sinicrope, Frank A. | |
| Validation of the prognostic impact of lymphocyte infiltration (LI) in patients (pts) with stage III colon cancer (CC) treated with adjuvant FOLFOX+/- cetuximab: A PETACC8 translational study | 2016 | Emile, Jean-François; Le Malicot, Karine; Tabernero, Josep; Mini, Enrico; Folprecht, Gunnar; Van Laethem, Jean-Luc; Julie, Catherine; Allard, Marc Antoine; Bennouna, Jaafar; Lepage, Come; Laurent-Puig, Pierre; Taïeb, Julien | |
| PROGNOSTIC VALUE OF KRAS MUTATIONS IN STAGE III COLON CANCER: POST-HOC ANALYSES OF THE PETACC8 PHASE III TRIAL | 2014 | Taieb, J.; Emile, J. F.; Le Malicot, K.; Zaanan, A.; Tabernero, J.; Mini, E.; Folprecht, G.; Van Laethem, J. L.; Thaler, J.; Bridgewater, J.; Petersen, L.; Van Cutsem, E.; Lepage, C.; Salazar, R.; Laurent-Puig, P.; Blons, H. | |
| PPROGNOSTIC VALUE OF KRAS MUTATIONS IN STAGE III COLON CANCER: POST-HOC ANALYSES OF THE PETACC8 PHASE III TRIAL | 2014 | Blons, H.; Emile, J.; Le Malicot, K.; Zaanan, A.; Tabernero, J.; Mini, E.; Folprecht, G.; van Laethem, J.; Thaler, J.; Bridgewater, J.A.; Petersen, L.; Van Cutsem, E.; Lepage, C.; Salazar, R.; Laurent-Puig, P.; Taieb, J. | |
| Analysis of DNA mismatch repair and clinical outcome in stage III colon cancers from patients treated with adjuvant FOLFOX +/- cetuximab in the PETACC8 and NCCTG N0147 adjuvant trials | 2015 | Zaanan, A.; Shi, Q.; Taieb, J.; Alberts, S.; Smyrk, T.; Julie, C.; Zawadi, A.; Tabernero, J.; Mini, E.; Goldberg, R.; Folprecht, G.; Van Laethem, J.L.; Le Malicot, K.; Sargent, D.; Laurent Puig, P.; Sinicrope, F. | |
| Prognostic value of BRAFV600E and KRAS exon 2 mutations in microsatellite stable stage III colon cancers from patients treated with FOLFOX + /- cetuximab: A pooled analysis from PETACC8 and N0147 trials | 2015 | Taieb, J.; Le Malicot, K.; Penault-Llorca, F.; Bouche, O.; Shi, Q.; Thibodeau, S.; Tabernero, J.; Mini, E.; Zaanan, Z.; Goldberg, R.; Folprecht, G.; Van Laethem, J.L.; Sargent, D.; Alberts, S.; Laurent Puig, P.; Sinicrope, F. | |
| Association of prognostic value of primary tumor location in stage III colon cancer with RAS and BRAF mutational status | 2017 | Taieb, Julien; Kourie, Hampig Raphael; Emile, Jean-François; Le Malicot, Karine; Balogoun, Ralyath; Tabernero, Josep; Mini, Enrico; Folprecht, Gunnar; Van Laethem, Jean-Luc; Mulot, Claire; Bouche, Olivier; Aparicio, Thomas; Michel, Pierre; Thaler, Josef; Bridgewater, John A.; Van Cutsem, Eric; Perkins, Géraldine; Salazar, Ramon; Lepage, Come; Laurent-Puig, Pierre | |
| Preliminary efficacy and safety data of nivolumab in never smoker patients with advanced squamous NSCLC: Experience from Italian sites participating in the Expanded Access Programme (EAP) | 2016 | Vitali, M.; Crinò, L.; Logroscino, A.F.; Ardizzoni, A.; Caponnetto, S.; Landi, L.; Bordi, P.; Luana, C.; Barbieri, F.; Santo, A.; Santarpia, M.; Carteni, G.; Mini, E.; Vasile, E.; Morgillo, F.; De Galitiis, F.; Conca, R.; Macerelli, M.; Tedde, N.; Vitiello, F. | |
| Prognostic value of primary tumor location in stage III colon cancer is associated with RAS and BRAF mutational status | 2017 | Taieb, Julien; Kourie Hampig, Raphael; Emile Jean, François; Le Malicot, Karine; Balogoun, Ralyath; Tabernero, Josep; Mini, Enrico; Folprecht, Gunnar; Van Laethem Jean, Luc; Mulot, Claire; Bouché, Olivier; Aparicio, Thomas; Michel, Pierre; Thaler, Josef; Bridgewater, John; Van Cutsem, Eric; Perkins, Géraldine; Lepage, Come; Salazar, Ramon; Laurent Puig, Pierre | |
| Italian nivolumab expanded access programme in non-squamous non-small cell lung cancer patients: Real-world results in never smokers and EGFR positive patients | 2017 | Garassino, M.C.; Cortesi, E.; Grossi, F.; Chiari, R.; Soto Parra, H.J.; Cascinu, S.; Cognetti, F.; Turci, D.; Blasi, L.; Bengala, C.; Mini, E.; Baldini, E.E.; Gamucci, T.; Ceresoli, G.L.; Antonelli, P.; Vasile, E.; Pagano, M.; Macerelli, M.; Lagroscino, A.; De Marinis, F. | |
| Inflammatory indexes strongly predict clinical outcome in patients (pts) with metastatic renal cell cancer (mRCC) treated with nivolumab: results from the Italian expanded access program (EAP) | 2017 | De Giorgi, U.; Procopio, G.; Guida, A.; Bearz, A.; Buti, S.; Basso, U.; Mitterer, M.; Ortega, C.; Bidoli, P.; Ferrau, F.; Crinò, L.; Frassoldati, A.; Marchetti, P.; Mini, E.; Scoppola, A.; Verusio, C.; Fornarini, G.; Cartenì, G.; Caserta, C.; Sternberg, C.N. | |
| Prognostic value of methylator phenotype in stage III colon cancer treated with oxaliplatin-based adjuvant chemotherapy | 2017 | Gallois, C.; Taieb, J.; Le Corre, D.; Le Malicot, K.; Tabernero, J.; Mulot, C.; Seitz, J-F.; Aparicio, T.; Folprecht, G.; Lepage, C.; Mini, E.; Van Laethem, J-L.; Emile, J.F.; Laurent-Puig, P. | |
| Retrospective analysis of 77 patients with ovarian cancer undergoing genetic testing for BRCA1 and BRCA2 mutations | 2017 | Tavella, K; Villanucci, A; Vannini, L; Rossi, V; Fantechi, B; Capone, G; Putignano, A L; Gensini, F; Porfirio, B; Amunni, G; Mazzei, T; Mini, E; Papi, L | |
| Association of postoperative carcinoembryonic antigen (CEA) levels with survival in stage III colon cancer (CC): Post hoc analysis of the MOSAIC and PETACC-8 studies | 2018 | Auclin, Edouard; Taieb, Julien; Lepage, Come; Aparicio, Thomas; Faroux, Roger; Mini, Enrico; Folprecht, Gunnar; Salazar, Ramon; Banzi, Maria; Louvet, Christophe; Van Laethem, Jean-Luc; Tabernero, Josep; Hickish, Tamas; De Gramont, Aimery; Andre, Thierry; Vernerey, Dewi | |
| Relative contribution of clinical and molecular features to outcome within low and high risk T and N groups in stage III colon cancer (CC) | 2019 | Sinicrope, Frank A.; Huebner, Lucas J.; Laurent-Puig, Pierre; Smyrk, Thomas C.; Tabernero, Josep; Mini, Enrico; Goldberg, Richard M.; Folprecht, Gunnar; Zaanan, Aziz; Le Malicot, Karine; Shi, Qian; Alberts, Steven R; Taieb, Julien | |
| Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor) | 2019 | Gasperoni S, Messerini L, Fumagalli E, Manglaviti S, Vincenzi B, Mazzocca Jr. A, Pantaleo MA, Nannini M, Badalamenti G, Incorvaia L, Ottaviano M, Palmieri G, Grignani G, D'Ambrosio L, Meoni G, Paderi A, Fancelli S, Caliman E, Tofani L, Enrico Mini. | |
| Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab | 2019 | De Giorgi, Ugo; Procopio, Giuseppe; Sabbatini, Roberto; Caserta, Claudia; Mitterer, Manfred; Ortega, Cinzia; Scoppola, Alessandro; Fornarini, Giuseppe; Ferraú, Francesco; Marchetti, Paolo; Verusio, Claudio; Mini, Enrico; Bidoli, Paolo; Buti, Sebastiano; Crino, Lucio; Basso, Umberto; Frassoldati, Antonio; Bearz, Alessandra; Carteni, Giacomo; Sternberg, Cora N. | |
| Is the predictive and prognostic impact of sporadic and familial microsatellite instable stage III colon cancer different? A pooled analysis of the PETACC8 and NCCTG N0147 (Alliance) trials | 2019 | Zaanan, Aziz; Shi, Qian; Taieb, Julien; Alberts, Steven R; Meyers, Jeffrey P.; Smyrk, Thomas C.; Julié, Catherine; Zawadi, Ayman; Tabernero, Josep; Mini, Enrico; Goldberg, Richard M.; Folprecht, Gunnar; VAN Laethem, Jean Luc; Le Malicot, Karine; Sargent, Daniel J.; Laurent-Puig, Pierre; Sinicrope, Frank A. | |
| Preface | 2019 | Brugnano, Luigi; Jackiewicz, Zdzisław; Podhaisky, Helmut; Sun, Yajuan; Tischendorf, Caren |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 - Contributo su rivista4448
- 4 - Contributo in atti di convegno (Proceedings)1
Data di pubblicazione
- In corso di stampa1
- 2020 - 2026395
- 2010 - 20192059
- 2000 - 20091389
- 1990 - 1999501
- 1980 - 198999
- 1975 - 19794
Editore
- EGU General Assembly 20201
- ELSEVIER SCIENCE INC1
- European Association for the Study of the Liver1
- Italian Pharmacol Soc; Dutch Pharmacol Soc1
- SPRINGER1
Rivista
- ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY182
- EUROPEAN UROLOGY. SUPPLEMENTS173
- EUROPEAN HEART JOURNAL136
- GEOPHYSICAL RESEARCH ABSTRACTS122
- JOURNAL OF PEPTIDE SCIENCE92
- ANNALS OF THE RHEUMATIC DISEASES74
- THE JOURNAL OF UROLOGY71
- JOURNAL OF HEPATOLOGY67
- CIRCULATION61
- JOURNAL OF PLANT PATHOLOGY61
Keyword
- partial nephrectomy47
- renal cell carcinoma46
- Multiple Sclerosis29
- landslide28
- systemic sclerosis26
- cellule dendritiche25
- multiple sclerosis25
- medical physics24
- pharmacology23
- peptide21
Lingua
- eng2701
- ita153
- fre5
- por1
- spa1
Accesso al fulltext
- no fulltext3214
- reserved711
- open518
- partially open5